Mikhail Ovanesov

Dr. Mikhail Ovanesov

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2007 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
MPM V Pletnikov
M V Pletnikov
YAY Ayhan
Y Ayhan
ONO Nikolskaia
O Nikolskaia
YXY Xu
Y Xu
MOMikhail Ovanesov
Mikhail Ovanesov
CRC A Ross
C A Ross

1 March 2006 in Biophysical Journal
Verified
Journal Article
Closed access
MPMikhail A. Panteleev
Mikhail A. Panteleev
MOMikhail Ovanesov
Mikhail Ovanesov
DKDmitrii A. Kireev
Dmitrii A. Kireev
ASAlexey M Shibeko
Alexey M Shibeko
ESElena Sinauridze
Elena Sinauridze
FAFazoil I. Ataullakhanov
Fazoil I. Ataullakhanov

1 November 2012 in Biophysical Journal
Verified
Journal Article
Closed access
NDN.M. Dashkevich
N.M. Dashkevich
MOMikhail Ovanesov
Mikhail Ovanesov
ABAnna N. Balandina
Anna N. Balandina
SKS.S. Karamzin
S.S. Karamzin
PSP.I. Shestakov
P.I. Shestakov
Fazoil I. AtaullakhanovFazoil I. Ataullakhanov
Fazoil I. Ataullakhanov

1 March 2016 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
JKJoseph Kotarek
Joseph Kotarek
CSChristine Stuart
Christine Stuart
SPSilvia H. De Paoli
Silvia H. De Paoli
JSJan Simak
Jan Simak
TLTsai-Lien Lin
Tsai-Lien Lin
JRJack A. Ragheb
Jack A. Ragheb

12 March 2012 in Transfusion
Verified
Journal Article
Closed access
PDF file
GDGregory W. Daniel
Gregory W. Daniel
MMMikhail Menis
Mikhail Menis
GSGayathri Sridhar
Gayathri Sridhar
DSDorothy Scott
Dorothy Scott
AWAnna E. Wallace
Anna E. Wallace
HIHector S. Izurieta
Hector S. Izurieta

1 February 2005 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
MOMikhail Ovanesov
Mikhail Ovanesov
NAN. M. Ananyeva
N. M. Ananyeva
MPM. A. Panteleev
M. A. Panteleev
FAF. I. Ataullakhanov
F. I. Ataullakhanov
ESE. L. Saenko
E. L. Saenko
Exposure of tissue factor (TF)-bearing cells to blood is the initial event in coagulation and intravascular thrombus formation. However, the mechanisms which determine thrombus growth remain poorly understood. To explore whether the procoagulant activity of vessel wall-bound cells regulates thrombus expansion, we studied in vitro spatial clot growth initiated by cultured human cells of different types in contact pathway-inhibited, non-flowing human plasma. Human aortic endothelial cells, smooth muscle cells, macrophages and lung fibroblasts differed in their ability to support thrombin generation in microplate assay with peaks of generated thrombin of 60 +/- 53 nmol L(-1), 135 +/- 57 nmol L(-1), 218 +/- 55 nmol L(-1) and 407 +/- 59 nmol L(-1) (mean +/- SD), respectively. Real-time videomicroscopy revealed the initiation and spatial growth phases of clot formation. Different procoagulant activity of cell monolayers was manifested as up to 4-fold difference in the lag times of clot formation. In contrast, the clot growth rate, which characterized propagation of clotting from the cell surface to plasma, was largely independent of cell type (< or = 30% difference). Experiments with factor VII (FVII)-, FVIII-, FX- or FXI-deficient plasmas and annexin V revealed that (i) cell surface-associated extrinsic Xase was critical for initiation of clotting; (ii) intrinsic Xase regulated only the growth phase; and (iii) the contribution of plasma phospholipid surfaces in the growth phase was predominant. We conclude that the role of TF-bearing initiator cells is limited to the initial stage of clot formation. The functioning of intrinsic Xase in plasma provides the primary mechanism of sustained and far-ranging propagation of coagulation leading to the physical expansion of a fibrin clot.